| What does ALT stand for in medical terminology? | Alanine transaminase | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: Triglyceride • Endocrinology: for uncontrolled hyperglycemia • Ophthalmology: at initial evaluation and every year • Nephrology: for deranged renal function • Cardiology: for CAD/HF/arrhythmia REFERRALS MONITORING • Blood glucose; FPG and 2 hours PPG once monthly more frequent as required including SMBG or CGM • HbA1c every 6-12 months ( 3 monthly if uncontrolled) • Annual monitoring : ECG, urine ACR (albumin creatinine ratio),dilated fundoscopy,foot examination Pin-prick sensation, monofilament test ,vibration, | 108 | definition | 0.940 | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: | 1 | page=1,block=71 | 0.700 | valid |
| What is the full form of the abbreviation BMI? | Body mass index | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: Triglyceride • Endocrinology: for uncontrolled hyperglycemia • Ophthalmology: at initial evaluation and every year • Nephrology: for deranged renal function • Cardiology: for CAD/HF/arrhythmia REFERRALS MONITORING • Blood glucose; FPG and 2 hours PPG once monthly more frequent as required including SMBG or CGM • HbA1c every 6-12 months ( 3 monthly if uncontrolled) • Annual monitoring : ECG, urine ACR (albumin creatinine ratio),dilated fundoscopy,foot examination Pin-prick sensation, monofilament test ,vibration, | 166 | definition | 0.940 | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: |
| What is the meaning of the abbreviation CAD? | Coronary artery disease | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: Triglyceride • Endocrinology: for uncontrolled hyperglycemia • Ophthalmology: at initial evaluation and every year • Nephrology: for deranged renal function • Cardiology: for CAD/HF/arrhythmia REFERRALS MONITORING • Blood glucose; FPG and 2 hours PPG once monthly more frequent as required including SMBG or CGM • HbA1c every 6-12 months ( 3 monthly if uncontrolled) • Annual monitoring : ECG, urine ACR (albumin creatinine ratio),dilated fundoscopy,foot examination Pin-prick sensation, monofilament test ,vibration, | 206 | definition | 0.940 | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: |
| What does ALT stand for in the context of medical tests? | Alanine transaminase | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: Triglyceride • Endocrinology: for uncontrolled hyperglycemia • Ophthalmology: at initial evaluation and every year • Nephrology: for deranged renal function • Cardiology: for CAD/HF/arrhythmia REFERRALS MONITORING • Blood glucose; FPG and 2 hours PPG once monthly more frequent as required including SMBG or CGM • HbA1c every 6-12 months ( 3 monthly if uncontrolled) • Annual monitoring : ECG, urine ACR (albumin creatinine ratio),dilated fundoscopy,foot examination Pin-prick sensation, monofilament test ,vibration, | 108 | definition | 0.940 | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: |
| What does CGM stand for in the medical terms listed? | Continuous glucose monitor | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: Triglyceride • Endocrinology: for uncontrolled hyperglycemia • Ophthalmology: at initial evaluation and every year • Nephrology: for deranged renal function • Cardiology: for CAD/HF/arrhythmia REFERRALS MONITORING • Blood glucose; FPG and 2 hours PPG once monthly more frequent as required including SMBG or CGM • HbA1c every 6-12 months ( 3 monthly if uncontrolled) • Annual monitoring : ECG, urine ACR (albumin creatinine ratio),dilated fundoscopy,foot examination Pin-prick sensation, monofilament test ,vibration, | 235 | definition | 0.940 | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: |
| What does the abbreviation ALT stand for? | Alanine transaminase | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: Triglyceride • Endocrinology: for uncontrolled hyperglycemia • Ophthalmology: at initial evaluation and every year • Nephrology: for deranged renal function • Cardiology: for CAD/HF/arrhythmia REFERRALS MONITORING • Blood glucose; FPG and 2 hours PPG once monthly more frequent as required including SMBG or CGM • HbA1c every 6-12 months ( 3 monthly if uncontrolled) • Annual monitoring : ECG, urine ACR (albumin creatinine ratio),dilated fundoscopy,foot examination Pin-prick sensation, monofilament test ,vibration, | 108 | definition | 0.900 | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: |
| What does the abbreviation BMI stand for? | Body mass index | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: Triglyceride • Endocrinology: for uncontrolled hyperglycemia • Ophthalmology: at initial evaluation and every year • Nephrology: for deranged renal function • Cardiology: for CAD/HF/arrhythmia REFERRALS MONITORING • Blood glucose; FPG and 2 hours PPG once monthly more frequent as required including SMBG or CGM • HbA1c every 6-12 months ( 3 monthly if uncontrolled) • Annual monitoring : ECG, urine ACR (albumin creatinine ratio),dilated fundoscopy,foot examination Pin-prick sensation, monofilament test ,vibration, | 166 | definition | 0.900 | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: |
| What does the abbreviation GDM stand for? | Gestational diabetes mellitus | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: Triglyceride • Endocrinology: for uncontrolled hyperglycemia • Ophthalmology: at initial evaluation and every year • Nephrology: for deranged renal function • Cardiology: for CAD/HF/arrhythmia REFERRALS MONITORING • Blood glucose; FPG and 2 hours PPG once monthly more frequent as required including SMBG or CGM • HbA1c every 6-12 months ( 3 monthly if uncontrolled) • Annual monitoring : ECG, urine ACR (albumin creatinine ratio),dilated fundoscopy,foot examination Pin-prick sensation, monofilament test ,vibration, | 370 | definition | 0.900 | Impaired fasting glucose: FPG 100-125 mg/dL; Impaired glucose tolerance: 140-199 mg/dL; HbA1c 5.7-6.4% ALT: Alanine transaminase AST: Aspartate aminotransferase BMI: Body mass index BP: Blood pressure CAD: Coronary artery disease CGM: Continuous glucose monitor CKD: Chronic kidney disease DTR: Deep tendon reflex ECG: Electrocardiogram FPG: Fasting plasma glucose GDM: Gestational diabetes mellitus HDL: High-density lipoprotein LDL: Low-density lipoprotein LFT: Liver function test OAD: Oral antidiabetic drug OGTT: Oral glucose tolerance test SMBG: Self-monitoring of blood glucose TG: |
| What are some additional investigations that might be conducted based on indications? | Echo, USG abdomen as indicated | INVESTIGATION • HbA1c • Creatinine • K+ • Fasting lipid profile • Urine routine examination and spot albumin: creatinine ratio# • LFT/ ALT, AST • ECG • Others like Echo, USG abdomen as indicated #These may best be carried out after initial glycaemic control | 164 | list | 0.820 | INVESTIGATION • HbA1c • Creatinine • K+ • Fasting lipid profile • Urine routine examination and spot albumin: creatinine ratio# • LFT/ ALT, AST • ECG • Others like Echo, USG abdomen as indicated #These may best be carried out after initial glycaemic control | 1 | page=1,block=22 | 0.700 | valid |
| What combination therapy is suggested for HbA1c levels between 8.5% and 10%? | Metformin + SU’s/TZD/ DPPIVi/SGLT2i /AGI/GLP-1RA | • Dietary modification • Avoidance of tobacco and restriction/ avoidance of alcohol • Physical activity • Pharmacotherapy: › HbA1c < 8.5%: Monotherapy- Metformin › HbA1c 8.5-10%: Dual therapy- Metformin + SU’s/TZD/ DPPIVi/SGLT2i /AGI/GLP-1RA › HbA1c > 10%: Basal Insulin+ Metformin + another OAD / triple OAD combination OR OR OR | 193 | list | 0.820 | • Dietary modification • Avoidance of tobacco and restriction/ avoidance of alcohol • Physical activity • Pharmacotherapy: › HbA1c < 8.5%: Monotherapy- Metformin › HbA1c 8.5-10%: Dual therapy- Metformin + SU’s/TZD/ DPPIVi/SGLT2i /AGI/GLP-1RA › HbA1c > 10%: Basal Insulin+ Metformin + another OAD / triple OAD combination OR OR OR | 1 | page=1,block=37 | 0.700 | valid |